Physician profile
Stephen B Scheibner
NPI 1033197173
$1,320.73
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $986 · 2020: $201 · 2021: $134.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $411.12 | 2019-2021 | |
| Celgene Corporation | $181.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.95 | 2019-2020 | |
| Leo Pharma INC. | $79.23 | 2019-2021 | |
| Janssen Biotech, INC. | $74.20 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $65.28 | 2019-2020 | |
| Pfizer INC. | $62.29 | 2019 | |
| Almirall LLC | $56.86 | 2019-2020 | |
| Biofrontera INC. | $50.30 | 2019 | |
| Genzyme Corporation | $38.98 | 2019-2020 | |
| Amgen INC. | $38.78 | 2019-2020 | |
| Galderma Laboratories, L.P. | $37.16 | 2019-2020 | |
| Dermira, INC. | $28.04 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $20.82 | 2019 | |
| Ucb, INC. | $17.75 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.04 | 2019 | |
| Merck Sharp & Dohme LLC | $11.52 | 2019 | |
| Epi Health, LLC | $9.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Scheibner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.